Evaluation of Peripapillary Retinal Nerve Fiber Layer and Macular Ganglion Cell-Inner Plexiform Layer Thickness in Type 2 Diabetes Mellitus Using Spectral-Domain Optical Coherence Tomography

Kavya - Bansal; Tanisha - Mittal; Rhydem - Aggarwal

doi:10.36948/ijfmr.2025.v07i06.59091

Evaluation of Peripapillary Retinal Nerve Fiber Layer and Macular Ganglion Cell-Inner Plexiform Layer Thickness in Type 2 Diabetes Mellitus Using Spectral-Domain Optical Coherence Tomography

Author(s)	Dr. Kavya - Bansal, Dr. Tanisha - Mittal, Mr. Rhydem - Aggarwal
Country	India
Abstract	Purpose: To assess peripapillary retinal nerve fiber layer (pRNFL) thickness and macular ganglion cell–inner plexiform layer (GC-IPL) thickness in patients with type 2 diabetes mellitus (DM) without and with early diabetic retinopathy (DR), and compare these parameters with age-matched healthy controls using spectral-domain optical coherence tomography (SD-OCT). Methods: A cross-sectional study was conducted on 100 eyes of 100 type 2 diabetic patients and 80 eyes of 80 healthy controls. Diabetic participants were categorized as Group 1: no DR, and Group 2: mild non-proliferative DR (NPDR). Exclusion criteria included macular edema, glaucoma, high myopia (>6D), and prior ocular surgery. SD-OCT (Cirrus HD-OCT, Carl Zeiss Meditec) was used to measure pRNFL thickness in four quadrants and average GC-IPL thickness. Correlation with duration of diabetes and HbA1c was analyzed. Results: Mean average pRNFL thickness was 97.3 ± 8.5 µm in controls, 90.6 ± 9.1 µm in Group 1, and 86.2 ± 10.2 µm in Group 2 (p < 0.001). Mean GC-IPL thickness was 82.1 ± 5.7 µm in controls, 77.5 ± 6.3 µm in Group 1, and 74.8 ± 6.9 µm in Group 2 (p < 0.001). Both pRNFL and GC-IPL thickness showed negative correlation with diabetes duration (r = –0.38, p < 0.001; r = –0.35, p = 0.002) and HbA1c levels (r = –0.41, p < 0.001; r = –0.33, p = 0.003). Conclusion: Significant thinning of pRNFL and GC-IPL occurs in type 2 diabetic patients before clinically detectable DR, indicating early neurodegenerative changes. SD-OCT can serve as a non-invasive biomarker for preclinical retinal neurodegeneration in diabetes
Keywords	Type 2 diabetes mellitus; retinal nerve fiber layer; ganglion cell–inner plexiform layer; SD-OCT; diabetic retinopathy
Field	Medical / Pharmacy
Published In	Volume 7, Issue 6, November-December 2025
Published On	2025-11-06
DOI	https://doi.org/10.36948/ijfmr.2025.v07i06.59091

View / Download PDF File

E-ISSN 2582-2160

doi

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads

Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 3 Cover Page Vol 8 Isu 2 Cover Page Vol 8 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Evaluation of Peripapillary Retinal Nerve Fiber Layer and Macular Ganglion Cell-Inner Plexiform Layer Thickness in Type 2 Diabetes Mellitus Using Spectral-Domain Optical Coherence Tomography

Share this